Antisense technology has emerged as a fast and conceivably high-throughput method for repressing genes due
to advancement in knowledge about DNA and RNA physiology. The limitations of antisense oligonucleotide
therapy in delivery strategies have been overcome in recent years. Antisense oligonucleotide treatment was
effectively applied towards targeting a wide range of therapeutic areas. With ongoing approvals of antisense
oligonucleotides, there is an expanding enthusiasm for increasing the utilization of these compounds for curing
various infections. This short survey gives a far-reaching comprehension of applications of antisense technology,
how they can be utilized therapeutically, and current endeavors to grow new antisense oligonucleotide
treatments that will add a forthcoming therapeutic approach for the treatment of various diseases.
LOX-1 Inhibition in ApoE KO Mice Using a Schizophyllan-based Antisense Oligonucleotide Therapy
